BamSEC and AlphaSense Join Forces
Learn More

Spero Therapeutics Inc. – Transcripts

NASDAQ: SPRO    
Share price (11/6/26): $1.03    
Market cap (11/6/26): $60.0 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 09/07/26 Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 08/12/26
CY 2025
Earnings Revised 08/12/25 Spero Therapeutics, Inc., Q2 2025 Earnings Call, Aug 12, 2025 08/12/25
Earnings Revised 03/27/25 Spero Therapeutics, Inc., Q4 2024 Earnings Call, Mar 27, 2025 03/27/25
CY 2024
Earnings Revised 08/05/24 Spero Therapeutics, Inc., Q2 2024 Earnings Call, Aug 05, 2024 08/05/24
Earnings Revised 03/13/24 Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 03/13/24
CY 2023
Earnings Revised 11/13/23 Spero Therapeutics, Inc., Q3 2023 Earnings Call, Nov 13, 2023 11/13/23
Earnings Revised 04/09/24 Spero Therapeutics, Inc., Q2 2023 Earnings Call, Aug 10, 2023 08/10/23
Earnings Revised 05/24/23 Spero Therapeutics, Inc., Q1 2023 Earnings Call, May 11, 2023 05/11/23
Earnings Revised 03/30/23 Spero Therapeutics, Inc., Q4 2022 Earnings Call, Mar 30, 2023 03/30/23
CY 2022
Earnings Revised 11/14/22 Spero Therapeutics, Inc., Q3 2022 Earnings Call, Nov 14, 2022 11/14/22
Other Revised 10/06/22 Spero Therapeutics, Inc. - Special Call 10/06/22
Earnings Revised 08/10/22 Spero Therapeutics, Inc., Q2 2022 Earnings Call, Aug 10, 2022 08/10/22
Earnings Revised 05/16/22 Spero Therapeutics, Inc., Q1 2022 Earnings Call, May 16, 2022 05/16/22
Other Revised 05/03/22 Spero Therapeutics, Inc. - Special Call 05/03/22
Earnings Revised 03/31/22 Spero Therapeutics, Inc., Q4 2021 Earnings Call, Mar 31, 2022 03/31/22
CY 2021
Earnings Revised 11/10/21 Spero Therapeutics, Inc., Q3 2021 Earnings Call, Nov 10, 2021 11/10/21
Earnings Revised 08/05/21 Spero Therapeutics, Inc., Q2 2021 Earnings Call, Aug 05, 2021 08/05/21
Earnings Revised 05/06/21 Spero Therapeutics, Inc., Q1 2021 Earnings Call, May 06, 2021 05/06/21
Earnings Revised 03/11/21 Spero Therapeutics, Inc., Q4 2020 Earnings Call, Mar 11, 2021 03/11/21
CY 2020
Earnings Revised 11/05/20 Spero Therapeutics, Inc., Q3 2020 Earnings Call, Nov 05, 2020 11/05/20
Other Revised 09/30/20 Spero Therapeutics, Inc. - Special Call 09/30/20
Other Revised 09/08/20 Spero Therapeutics, Inc. - Special Call 09/08/20
Earnings Revised 08/06/20 Spero Therapeutics, Inc., Q2 2020 Earnings Call, Aug 06, 2020 08/06/20
Other Revised 05/13/20 Spero Therapeutics, Inc. Presents at BofA Securities 2020 Health Care Conference, May-13-2020 01:00 PM 05/13/20
Earnings Revised 05/08/20 Spero Therapeutics, Inc., Q1 2020 Earnings Call, May 08, 2020 05/08/20
Other Revised 03/02/20 Spero Therapeutics, Inc. Presents at Cowen and Company 40th Annual Health Care Conference, Mar-02-2020 12:00 PM 03/02/20
CY 2019
Other Revised 12/05/19 Spero Therapeutics, Inc. - Special Call 12/05/19
Other Revised 05/15/19 Spero Therapeutics, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-15-2019 04:35 PM 05/15/19
CY 2018
Other Revised 05/16/18 Spero Therapeutics, Inc. Presents at Bank of America Merrill Lynch 2018 Healthcare Conference, May-16-2018 05:15 PM 05/16/18